Alessandro Piergentili

Via Madonna Delle Carceri
Camerino, 62032, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Probing chemical space and conformational changes for subtype-selective orexin receptor antagonists.

Probing chemical space and conformational changes for subtype-selective orexin receptor antagonists.

Journal: RSC medicinal chemistry

Published: February 12, 2026

New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma.

New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma.

Journal: Journal of medicinal chemistry

Published: March 29, 2025

Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma.

Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 18, 2025

Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma.

Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma.

Journal: Journal of medicinal chemistry

Published: June 04, 2024

New potent muscarinic receptor ligands bearing the 1,4-dioxane nucleus: Investigation on the nature of the substituent in position 2.

New potent muscarinic receptor ligands bearing the 1,4-dioxane nucleus: Investigation on the nature of the substituent in position 2.

Journal: Archiv der Pharmazie

Published: May 02, 2024

Advances in drug design and therapeutic potential of selective or multitarget 5-HT1A receptor ligands.

Advances in drug design and therapeutic potential of selective or multitarget 5-HT1A receptor ligands.

Journal: Medicinal research reviews

Published: December 21, 2023

The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior.

The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior.

Journal: Pharmacological research

Published: June 20, 2023

Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders.

Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders.

Journal: Medicinal research reviews

Published: December 29, 2022

Properly Substituted Benzimidazoles as a New Promising Class of Nicotinate Phosphoribosyltransferase (NAPRT) Modulators.

Properly Substituted Benzimidazoles as a New Promising Class of Nicotinate Phosphoribosyltransferase (NAPRT) Modulators.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 21, 2022

Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma.

Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma.

Journal: Journal of medicinal chemistry

Published: September 13, 2022

Investigating the role of the central melanocortin system in stress and stress-related disorders.

Investigating the role of the central melanocortin system in stress and stress-related disorders.

Journal: Pharmacological research

Published: August 26, 2022

Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects.

Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects.

Journal: Inorganic chemistry

Published: March 14, 2022

Showing 1-12 of 52

Last Updated: 09/26/2026